In the news release, Arcadia Biosciences Announces Date of Second-Quarter 2019 Financial Results and Business Highlights Conference Call, issued 05-Aug-2019 by Arcadia Biosciences, Inc. over PR Newswire, we are advised by the company that the the date in the first paragraph, first sentence, should read "August 14, 2019" rather than "August 7, 2019" as originally issued inadvertently. The complete, corre

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to $41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms -- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to $79.3 Million;

ATLANTA, Aug. 5, 2019 /PRNewswire/ -- DLH Holdings Corp. (NASDAQ: DLHC) ("DLH" or the "Company"), a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for its fiscal third quarter ended June 30, 2019.  HighlightsThe Company complete

NASHVILLE, Tenn., Aug. 5, 2019 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter ended June 30, 2019.

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the second quarter ended June 30, 2019.Second Quarter Highlights:Initiated the Phase 3 randomized clinical trial, evaluating the combination o

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a clinical stage biopharmaceutical company, today reported financial results for the three- and six- month period ended June 30, 2019. Second quarter and recent highlights include:Raised

REDWOOD CITY, Calif., Aug. 5, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its second quarter 2019 financial results."We successfully executed our first full quarter

PHILADELPHIA, Aug. 5, 2019 /PRNewswire/ -- Military families covered by TRICARE, the health care program for uniformed service members and their families, report lower access to care and satisfaction with the quality of care than civilian families who have private or public coverage for their kids, according to a

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, today reported additional data from its Phase 3 'AMPOWER' clinical trial of Amphora® for the prevention of pregnancy.  These findings reveal that the use of Amphora, a first-in-class investigational Multipurpose Vaginal pH Re

FRISCO, Texas, Aug. 5, 2019 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of comprehensive home care services, today announced its financial results for the second quarter and six months ended June 30, 2019. Net service revenues were $149.7 million for the second quarter of 20